CONMED Corp — Director's Dealing 2018

Feb 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-02-01

Reporting Person: Cohen Heather L (EVP CORP HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	Common Stock	M	2000	$16.46	Acquired	14626	Direct
2018-02-01	Common Stock	F	1101	$63.35	Disposed	13525	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Sars (Stock Appreciation Rights)	$16.46	M	2000	Disposed	2019-06-01	Common Stock (2000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.